KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Treasury Shares (2017 - 2025)

TherapeuticsMD's Treasury Shares history spans 10 years, with the latest figure at $26000.0 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 1200.0% year-over-year to $26000.0; the TTM value through Dec 2025 reached $26000.0, up 1200.0%, while the annual FY2025 figure was $26000.0, 1200.0% up from the prior year.
  • Treasury Shares reached $26000.0 in Q4 2025 per TXMD's latest filing, up from $5000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.6 million in Q3 2021 to a low of $5.0 in Q1 2024.
  • Average Treasury Shares over 5 years is $366953.8, with a median of $48500.0 recorded in 2022.
  • Peak YoY movement for Treasury Shares: crashed 100.0% in 2024, then skyrocketed 99900.0% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $164.0 in 2021, then skyrocketed by 34656.1% to $57000.0 in 2022, then fell by 29.82% to $40000.0 in 2023, then plummeted by 95.0% to $2000.0 in 2024, then surged by 1200.0% to $26000.0 in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Treasury Shares are $26000.0 (Q4 2025), $5000.0 (Q1 2025), and $2000.0 (Q4 2024).